Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

NCT05384587

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope Phoenix Scottsdale, Arizona, United States
  • USO Arizona Oncology Tucson, Arizona, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia

NCT02153580

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View Trial Details
Active, Not Recruiting

Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial

NCT05556720

Conditions
Blood Protein Disorders, COVID-19 Vaccines, Cardiovascular Diseases, +27 more
Locations
  • St Vincents Hospital Darlinghurst, New South Wales, Australia
  • Prince Of Wales Hospital Randwick, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Womens Hospital Herston, Queensland, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

NCT05878184

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +21 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Medical Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979

Conditions
Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

NCT04606433

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View Trial Details
Active, Not Recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

NCT05104775

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +11 more
Locations
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions